Potent and selective inhibitor of the mitotic kinesin CENP-E (GSK923295A), demonstrates a novel mechanism of inhibiting tumor cell proliferation and shows activity against a broad panel of human tumor cell lines in vitro

被引：0

|

作者：

Sutton, David ^{[1
]}

Gilmartin, Aidan G. ^{[1
]}

Kusnierz, Anna M. ^{[1
]}

Sung, Chiu-Mei ^{[1
]}

Luo, Lusong ^{[1
]}

Carson, Jeffrey D. ^{[1
]}

Laquerre, Sylvie G. ^{[1
]}

Comwell, William D. ^{[1
]}

King, Andrew G. ^{[1
]}

Knight, Steven D. ^{[1
]}

Dhanak, Dashyant ^{[1
]}

Bergnes, Gustave ^{[2
]}

Qian, Xiangping ^{[2
]}

Chua, Penelope ^{[2
]}

Wood, Kenneth W. ^{[2
]}

Huang, Pearl S. ^{[1
]}

Weber, Barbara L. ^{[1
]}

Copeland, Robert A. ^{[1
]}

Jackson, Jeffrey R. ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, College Pk, MD USA

[2] Cytokinet, San Francisco, CA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3370S / 3370S

页数：1

相关论文

共 5 条

[1] GSK923925A, a novel and selective CENP-E inhibitor, induces pharmacodynamic effects and anti-tumor activity in human Colo205 xenografts
Sutton, D.
Liu, Q.
Moss, K. G.
Wood, K. W.
Jackson, J. R.
EJC SUPPLEMENTS, 2008, 6 (12): : 107 - 107
[2] 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography is an early biomarker for tumor growth inhibition of human Colo205 xenografts by the novel and selective CENP-E inhibitor, GSK923295A
Sutton, D.
Fleming, R. A.
Wood, K. W.
Jackson, J. R.
EJC SUPPLEMENTS, 2008, 6 (12): : 108 - 109
[3] Broad spectrum and potent anti tumor activity of YM155, a novel small molecule survivin suppressant, against a large scale panel of human tumor cell lines
Nakahara, T.
Takeuchi, M.
Kita, A.
Yamanaka, K.
Koutoku, H.
Kinoyama, I.
Matsuhisa, A.
Sasamata, M.
EJC SUPPLEMENTS, 2006, 4 (12): : 122 - 122
[4] Uniform potent activity of the antiproliferative metal chelate trans-bis(resorcylaldoximato)copper(II) against a large panel of human tumor cell lines in vitro
Elo, H
CHEMOTHERAPY, 2004, 50 (05) : 229 - 233
[5] Discovery of D-1553, a novel and selective KRas-G12C Inhibitor with potent anti-tumor activity in a broad spectrum of tumor cell lines and xenograft models.
Shi, Zhe
Weng, Jifang
Fan, Xiaochong
Wang, Emma
Zhu, Qingqing
Tao, Liangshan
Han, Zixing
Wang, Zhenwu
Niu, Haotao
Jiang, Yueheng
Zhang, Ling
Dai, Xing
Wang, Yaolin
CANCER RESEARCH, 2021, 81 (13)